Vivopod-CV

Your Go-To for Resistant Yet Routine Infections

10x10 Tablets

Pharma

Antibacterial

Product highlights

Dual antibacterial action with Gram-positive & Gram-negative coverage
Deeper tissue penetration for effective infection control
Effective in mixed and complicated infections
β-lactamase protection ensures higher efficacy
Reliable against resistant respiratory pathogens

Vivopod-CV combines Cefpodoxime 200mg with Clavulanic Acid 125mg to overcome bacterial resistance and improve efficacy.

Dosage Form

Tablet

Product Name

Vivopod-CV

Composition

Vivopod-CV: Cefpodoxime 200mg + Clavulanic Acid 125mg

Therapeutic Segment

Antibiotics / Anti-infectives

Pharmacological Action

Broad-spectrum antibacterial with enhanced tissue penetration and β-lactamase protection

Mechanism

Cefpodoxime inhibits bacterial cell wall synthesis, Ofloxacin inhibits bacterial DNA gyrase, and Clavulanic Acid protects against β-lactamase enzymes.

Key Clinical Benefits

Effective against resistant pathogens
Improved efficacy in complicated infections
Deeper tissue penetration
Broad-spectrum Gram-positive & Gram-negative coverage
Strong first-line option for OPD infections

Key Indications

Respiratory tract infections
ENT infections
Urinary tract infections
Skin & soft tissue infections
Typhoid fever
Gynecological infections
Gastrointestinal infections

Administration

Oral administration after meals for improved absorption

Recommended Usage

1 tablet twice daily or as prescribed by the physician

Dosage Form

Tablet

Product Name

Vivopod-CV

Composition

Vivopod-CV: Cefpodoxime 200mg + Clavulanic Acid 125mg

Therapeutic Segment

Antibiotics / Anti-infectives

Pharmacological Action

Antibiotics / Anti-infectives

Mechanism

Cefpodoxime inhibits bacterial cell wall synthesis, Ofloxacin inhibits bacterial DNA gyrase, and Clavulanic Acid protects against β-lactamase enzymes.

Key Clinical Benefits